Composition:
Each ml contains: Clindamycin Hydrochloride 27.14 mg Equivalent to Clindamycin 25 mg
Properties:
Clindamycin is lincosamide antibiotic, act by binding to the 50S ribosomal subunit of susceptible bacteria, thereby inhibiting peptide bond formation. Most aerobic gram positive cocci are susceptible to the lincosamides (Strep. faecalis is not) including Staphylococcus, and Streptococci. Other organisms that are generally susceptible include: Corynebacterium diphtheriae, Nocardia asteroides, Erysepelothrix, Toxoplasma, and Mycoplasma sp. Anaerobic bacteria that are generally susceptible to the lincosamides include: Clostridium perfringens, C. tetani (not C. difficile), Bacteroides (including many strains of B.fragilis), Fusobacterium, Peptostreptococcus, Actinomyces, and Peptococcus.
Indications:
Dogs: For treatment of infected wounds, abscesses and dental infections caused by or associated with Staphylococcus spp., Streptococcus spp., Bacteroides spp., Fusobacterium necrophorum and Clostridium perfringens
For treatment of osteomyelitis caused by Staphylococcus aureus.
Cats: For treatment of infected wounds, abscesses and dental infections caused by or associated with Staphylococcus aureus, Staphylococcus intermedius, Streptococcus spp., Clostridium perfringens and Bacteroides fragilis.
Target Species:
Dogs and Cats.